Are we addressing the top 10 research priorities in IBD?

Abstract

BackgroundSince publication of the top 10 research priorities in inflammatory bowel disease (IBD) based on the James Lind Alliance Priority Setting Partnership, the question remains whether this has influenced the IBD-research landscape. This study aimed to create an overview of the current distribution of research interests of trials in the UK.MethodsThe ClinicalTrials.gov database and European Union Clinical Trials Register were screened for clinical trials set up from 9 August 2016 to 16 November 2019 in the UK involving adult patients with IBD.ResultsOf 20 non-industry-sponsored studies, a quarter investigated treatment strategies considering efficacy, safety and cost-effectiveness (priority 1). Four evaluated the role of diet (priorities 3 and 7). Development/assessment of biomarkers for patient stratification (priority 2) and fatigue (priority 8) were subject of three studies. IBD-related pain and control of diarrhoea/incontinence were each subject of 2 studies (priorities 4 and 6). The effect of gut microbiota (priority 10) and optimal strategy for perianal Crohn’s disease (priority 5) was the focus of 2 studies each. One study evaluated surgery for terminal ileal Crohn’s disease (priority 9). Of 63 industry-sponsored studies, 59 focused on priority 1.ConclusionsThis study presents an impression of the breadth of the IBD-research landscape in the UK, in light of the top 10 research priorities published in 2016. Optimal treatment strategy has been the most studied research priority by academic and industry-sponsored trials. Fewer studies focused on patient-reported outcomes. It remains debatable to what extent the current research landscape adequately represents all stakeholders’ viewpoints on needs for expanded knowledge in IBD, particularly the patients’ perspective.

Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data

“…Assessing PROs provides insight into patients’ perspectives of treatment efficacy, which is lacking in IBD, and promotes patient-centered care. 22 , 23 Therefore, the assessment and monitoring of symptoms of UC need to be improved. Additionally, further research of fatigue, bowel urgency, and abdominal pain in UC and the investigation of novel therapies and interventions that could ameliorate these effects is also needed.…”

Nutritional status in perianal Crohn’s disease: are we underestimating the impact?

“…Despite medical and surgical intervention, a considerable number of patients experience refractory disease, and up to 20% may require proctectomy with a permanent stoma ( 10 ). Therefore, the investigation into factors that may influence the outcome of perianal disease is one of the key areas of research in CD ( 11 ).…”

Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial

“…2 Despite the progress in controlling intestinal inflammation, fatigue remains an unmet clinical need, leading to reduced quality of life, 3,4 absenteeism, and presenteeism. 5,6 The pathogenesis of fatigue is poorly understood and is multifactorial. Factors such as inflammation, psychological comorbidities, metabolic alterations, micronutrient deficiencies, and sleep disturbances are thought to play a role.…”